Abstract:We previously reported an Arg1420His mutation in ABCC8 in an Indigenous community that resulted in hyperinsulinemic hypoglycemia in infancy in a homozygous carrier and a doubling in type 2 diabetes (T2D) risk in heterozygous carriers (3% of the population). Previous studies of ABCC8 mutations have suggested a loss of pancreatic beta cells as a probable cause of future T2D. To understand the pathomechanism behind the increased risk of T2D due to the Arg1420His mutation, we generated two sets of isogenic iPSCs from two different Indigenous community members. These iPSCs were used to generate pancreatic islets and assess insulin secretion using a dynamic glucose stimulated insulin secretion (D-GSIS) assay when the islets were immature (resembling fetal islets) and during multiple days after maturation (resembling adult islets). In immature islets, the D-GSIS assay confirmed the clinical phenotype of significantly higher insulin secretion in islets with the His-allele under basal conditions (2mM glucose) and a lower response to diazoxide in islets homozygous for the His-allele. Both Arg1420 and His1420 mature islets had lower insulin secretion under basal conditions, however, insulin secretory response to high glucose (20mM) and Tolbutamide (sulphonylurea) was significantly lower in islets heterozygous for the His-allele whereas no response was seen in islets homozygous for the His-allele despite having similar proportion of beta cells as assessed by flow cytometry (~50% cells positive for INS and NKX6-1). This suggests a mechanism other than beta cell loss as the cause of lower insulin secretory response in these impaired islets. Single cell RNA sequencing showed higher expression of G6PC2, which inhibits insulin secretion by opposing the action of GCK, in islets with the His-allele. Our ongoing work includes knockout of G6PC2 in the isogenic iPSCs and using a GCK activator (Dorzagliatin) to correct the insulin secretory response to high glucose in the His-allele carrying islets. Disclosure A.K.Nair: None. K.Barkho: None. M.Traurig: None. R.G.Nelson: None. C.Bogardus: None. L.Baier: None. Funding National Institute of Diabetes and Digestive and Kidney Diseases

Modeling Congenital Hyperinsulinism with ABCC8 -Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9

Congenital Hyperinsulinism in China: A Review of Chinese Literature over the Past 15 Years

Generation of an Abcc8 Heterozygous Mutation Human Embryonic Stem Cell Line Using CRISPR/Cas9

Functional characterization of inactivating ABCC8 variants causing congenital hyperinsulinism

CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion

A Homozygous Exonic Variant Leading to Exon Skipping in ABCC8 As the Cause of Severe Congenital Hyperinsulinism

Case report: Congenital hyperinsulinemia with ABCC8 gene mutations

Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8

Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-Channel

Uncovering the Molecular Pathogenesis of Congenital Hyperinsulinism by Panel Gene Sequencing in 32 Chinese Patients.

Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiency

A Xenograft and Cell Line Model of SDH-deficient Pheochromocytoma Derived from Sdhb+/− Rats

286-OR: Using iPSC-Derived Islets to Model the Effect of an ABCC8 Arg1420His Mutation in Fetal and Adult Islets

Insulin regulates human pancreatic endocrine cell differentiation in vitro

Genotype and Phenotype Analysis of a Cohort of Patients with Congenital Hyperinsulinism Based on DOPA-PET CT Scanning.

Aberrant Splicing of INS Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes

Genetic Heterogeneity Correlated with Phenotypic Variability

Cell identity dynamics and insight into insulin secretagogues when employing stem cell-derived islets for disease modeling

Neonatal congenital hyperinsulinism：one case report and literature review

Genome-edited zebrafish model of ABCC8 loss-of-function disease

Neonatal Hyperinsulinism with an ABCC8 Mutation: A Case Report